MANISCALCO, Francesco
 Distribuzione geografica
Continente #
EU - Europa 132
NA - Nord America 121
AS - Asia 73
SA - Sud America 8
Totale 334
Nazione #
US - Stati Uniti d'America 120
RU - Federazione Russa 57
CN - Cina 34
GB - Regno Unito 31
SG - Singapore 21
IE - Irlanda 12
DE - Germania 11
HK - Hong Kong 9
SE - Svezia 8
FR - Francia 6
BR - Brasile 4
FI - Finlandia 3
VN - Vietnam 3
AR - Argentina 2
IT - Italia 2
UA - Ucraina 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
CA - Canada 1
CO - Colombia 1
EC - Ecuador 1
ID - Indonesia 1
IQ - Iraq 1
IR - Iran 1
KR - Corea 1
Totale 334
Città #
Southend 28
Dallas 18
Moscow 17
Chandler 15
Ashburn 12
Dublin 12
Houston 10
Singapore 10
Hong Kong 8
Jacksonville 8
New York 8
Munich 7
Beijing 6
Jinan 6
Los Angeles 6
Ho Chi Minh City 3
Brooklyn 2
Haikou 2
Helsinki 2
Lawrence 2
Nanchang 2
Nanjing 2
Princeton 2
Shenyang 2
The Dalles 2
Tianjin 2
Baghdad 1
Baoding 1
Belo Horizonte 1
Bologna 1
Boston 1
Burlington 1
Cañuelas 1
Central 1
Changsha 1
Charlotte 1
City of London 1
Columbus 1
Costa Mesa 1
Cuenca 1
Curitiba 1
Dearborn 1
Denver 1
General Rodríguez 1
Hangzhou 1
Jakarta 1
Jiaxing 1
Lancaster 1
London 1
Redondo Beach 1
Rio de Janeiro 1
Riva 1
San Francisco 1
San Mateo 1
Santa Clara 1
Santiago de Cali 1
Seattle 1
Seoul 1
Sindelfingen 1
Stockholm 1
São Paulo 1
Tampa 1
Vigasio 1
Wilmington 1
Totale 232
Nome #
Clinical significance of LAIR1 (CD305) as assessed by flow cytometry in a prospective series of patients with chronic lymphocytic leukemia 151
IDENTIFICATION AND CHARACTERIZATION OF CANDIDATE MYELOID DERIVED SUP- PRESSOR CELLS IN THE MONONUCLEAR FRACTION OF PERIPHERAL BLOOD SAMPLES FROM PATIENTS AFFECTED BY NON-HODGKIN LYMPHOMA (NHL), HODGKIN LYMPHOMA (HL), AND MULTIPLE MYELOMA (MM) 131
null 55
Totale 337
Categoria #
all - tutte 1.139
article - articoli 1.139
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.278


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20216 0 0 0 0 0 3 0 0 0 0 3 0
2021/202219 2 7 0 1 2 0 0 1 0 0 1 5
2022/202345 2 5 2 7 4 17 0 1 6 0 1 0
2023/202426 1 1 1 2 3 7 1 3 0 3 3 1
2024/202556 3 1 1 11 2 2 3 6 7 1 6 13
2025/2026118 11 16 15 32 44 0 0 0 0 0 0 0
Totale 337